Royal Philips raised its full-year guidance after swinging to net profit for the third quarter of the year on higher sales, with growth in all segments and geographies.

The Dutch health-technology company said Monday that it now expects to report a 6% to 7% rise in comparable sales this year compared with previous guidance for mid-single-digit comparable growth.